These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 21748294)

  • 1. Correlation of breast cancer susceptibility loci with patient characteristics, metastasis-free survival, and mRNA expression of the nearest genes.
    Riaz M; Berns EM; Sieuwerts AM; Ruigrok-Ritstier K; de Weerd V; Groenewoud A; Uitterlinden AG; Look MP; Klijn JG; Sleijfer S; Foekens JA; Martens JW
    Breast Cancer Res Treat; 2012 Jun; 133(3):843-51. PubMed ID: 21748294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic variation in ALCAM and other chromosomal instability genes in breast cancer survival.
    Varadi V; Bevier M; Grzybowska E; Johansson R; Enquist-Olsson K; Henriksson R; Butkiewicz D; Pamula-Pilat J; Tecza K; Hemminki K; Lenner P; Försti A
    Breast Cancer Res Treat; 2012 Jan; 131(1):311-9. PubMed ID: 21935604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Common genetic variants associated with breast cancer in Korean women and differential susceptibility according to intrinsic subtype.
    Han W; Woo JH; Yu JH; Lee MJ; Moon HG; Kang D; Noh DY
    Cancer Epidemiol Biomarkers Prev; 2011 May; 20(5):793-8. PubMed ID: 21415360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of genome-wide association study newly identified genetic variants for breast cancer in Chinese women of Heilongjiang Province.
    Jiang Y; Han J; Liu J; Zhang G; Wang L; Liu F; Zhang X; Zhao Y; Pang D
    Breast Cancer Res Treat; 2011 Jul; 128(1):251-7. PubMed ID: 21197568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A genetic variant in p63 (rs17506395) is associated with breast cancer susceptibility and prognosis.
    Zhang N; Huo Q; Wang X; Chen X; Long L; Guan X; Jiang L; Ma T; Hu W; Yang Q
    Gene; 2014 Feb; 535(2):170-6. PubMed ID: 24316488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of common genetic variants with breast cancer risk and clinicopathological characteristics in a Chinese population.
    Chan M; Ji SM; Liaw CS; Yap YS; Law HY; Yoon CS; Wong CY; Yong WS; Wong NS; Ng R; Ong KW; Madhukumar P; Oey CL; Tan PH; Li HH; Ang P; Ho GH; Lee AS
    Breast Cancer Res Treat; 2012 Nov; 136(1):209-20. PubMed ID: 22965832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of breast cancer susceptibility loci on 2q35, 3p24, 17q23 and FGFR2 genes in Taiwanese women with breast cancer.
    Lin CY; Ho CM; Bau DT; Yang SF; Liu SH; Lin PH; Lin TH; Tien N; Shih MC; Lu JJ
    Anticancer Res; 2012 Feb; 32(2):475-82. PubMed ID: 22287734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MDR1 C3435T polymorphism in patients with breast cancer.
    Turgut S; Yaren A; Kursunluoglu R; Turgut G
    Arch Med Res; 2007 Jul; 38(5):539-44. PubMed ID: 17560460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene expression of estrogen receptor, progesterone receptor and microtubule-associated protein Tau in high-risk early breast cancer: a quest for molecular predictors of treatment benefit in the context of a Hellenic Cooperative Oncology Group trial.
    Pentheroudakis G; Kalogeras KT; Wirtz RM; Grimani I; Zografos G; Gogas H; Stropp U; Pectasides D; Skarlos D; Hennig G; Samantas E; Bafaloukos D; Papakostas P; Kalofonos HP; Pavlidis N; Fountzilas G
    Breast Cancer Res Treat; 2009 Jul; 116(1):131-43. PubMed ID: 18668363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of matrix metalloproteinase-8 gene variation with breast cancer prognosis.
    Decock J; Long JR; Laxton RC; Shu XO; Hodgkinson C; Hendrickx W; Pearce EG; Gao YT; Pereira AC; Paridaens R; Zheng W; Ye S
    Cancer Res; 2007 Nov; 67(21):10214-21. PubMed ID: 17974962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic variation in genes encoding for polymerase ζ subunits associates with breast cancer risk, tumour characteristics and survival.
    Varadi V; Bevier M; Grzybowska E; Johansson R; Enquist K; Henriksson R; Butkiewicz D; Pamula-Pilat J; Tecza K; Hemminki K; Lenner P; Försti A
    Breast Cancer Res Treat; 2011 Aug; 129(1):235-45. PubMed ID: 21455670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A haplotype analysis of HER-2 gene polymorphisms: association with breast cancer risk, HER-2 protein expression in the tumor, and disease recurrence in Korea.
    Han W; Kang D; Lee JE; Park IA; Choi JY; Lee KM; Bae JY; Kim S; Shin ES; Lee JE; Shin HJ; Kim SW; Kim SW; Noh DY
    Clin Cancer Res; 2005 Jul; 11(13):4775-8. PubMed ID: 16000574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The risk allele of SNP rs3803662 and the mRNA level of its closest genes TOX3 and LOC643714 predict adverse outcome for breast cancer patients.
    Gudmundsdottir ET; Barkardottir RB; Arason A; Gunnarsson H; Amundadottir LT; Agnarsson BA; Johannsson OT; Reynisdottir I
    BMC Cancer; 2012 Dec; 12():621. PubMed ID: 23270421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FGFR4 Arg388 allele is associated with resistance to adjuvant therapy in primary breast cancer.
    Thussbas C; Nahrig J; Streit S; Bange J; Kriner M; Kates R; Ulm K; Kiechle M; Hoefler H; Ullrich A; Harbeck N
    J Clin Oncol; 2006 Aug; 24(23):3747-55. PubMed ID: 16822847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of aggressive breast cancer in women of Han nationality carrying TGFB1 rs1982073 C allele and FGFR2 rs1219648 G allele in North China.
    Chen XH; Li XQ; Chen Y; Feng YM
    Breast Cancer Res Treat; 2011 Jan; 125(2):575-82. PubMed ID: 20640597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-6 -174G-->C polymorphism is associated with improved outcome in high-risk breast cancer.
    DeMichele A; Martin AM; Mick R; Gor P; Wray L; Klein-Cabral M; Athanasiadis G; Colligan T; Stadtmauer E; Weber B
    Cancer Res; 2003 Nov; 63(22):8051-6. PubMed ID: 14633738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymorphisms in the H19 gene and the risk of bladder cancer.
    Verhaegh GW; Verkleij L; Vermeulen SH; den Heijer M; Witjes JA; Kiemeney LA
    Eur Urol; 2008 Nov; 54(5):1118-26. PubMed ID: 18262338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic variants in FGFR2 and MAP3K1 are associated with the risk of familial and early-onset breast cancer in a South-American population.
    Jara L; Gonzalez-Hormazabal P; Cerceño K; Di Capua GA; Reyes JM; Blanco R; Bravo T; Peralta O; Gomez F; Waugh E; Margarit S; Ibañez G; Romero C; Pakomio J; Roizen G
    Breast Cancer Res Treat; 2013 Jan; 137(2):559-69. PubMed ID: 23225170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. WWOX--the FRA16D cancer gene: expression correlation with breast cancer progression and prognosis.
    Płuciennik E; Kusińska R; Potemski P; Kubiak R; Kordek R; Bednarek AK
    Eur J Surg Oncol; 2006 Mar; 32(2):153-7. PubMed ID: 16360296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic polymorphisms and breast cancer risk: evidence from meta-analyses, pooled analyses, and genome-wide association studies.
    Peng S; Lü B; Ruan W; Zhu Y; Sheng H; Lai M
    Breast Cancer Res Treat; 2011 Jun; 127(2):309-24. PubMed ID: 21445572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.